Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus
Viruses · 2024
DOI: 10.3390/v16030363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Anna K Kuderna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Ulm University Medical Center, 89081 Ulm, Germany. Hauptthemen laut MEDLINE: Cytomegalovirus, Virus Replication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Forschungsgemeinschaft in the framework of Research Unit FOR5200 DEEP-DV, International Graduate School in Molecular Medicine Ulm.
Abstract (Originalsprache)
The chromatin-remodeler SPOC1 (PHF13) is a transcriptional co-regulator and has been identified as a restriction factor against various viruses, including human cytomegalovirus (HCMV). For HCMV, SPOC1 was shown to block the onset of immediate-early (IE) gene expression under low multiplicities of infection (MOI). Here, we demonstrate that SPOC1-mediated restriction of IE expression is neutralized by increasing viral titers. Interestingly, our study reveals that SPOC1 exerts an additional antiviral function beyond the IE phase of HCMV replication. Expression of SPOC1 under conditions of high MOI resulted in severely impaired viral DNA replication and viral particle release, which may be attributed to inefficient viral transcription. With the use of click chemistry, the localization of viral DNA was investigated at late time points after infection. Intriguingly, we detected a co-localization of SPOC1, RNA polymerase II S5P and polycomb repressor complex 2 (PRC2) components in close proximity to viral DNA in areas that are hypothesized to harbor viral transcription sites. We further identified the N-terminal domain of SPOC1 to be responsible for interaction with EZH2, a subunit of the PRC2 complex. With this study, we report a novel and potent antiviral function of SPOC1 against HCMV that is efficient even with unrestricted IE gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Virology, Ulm University Medical Center, 89081 Ulm, Germany.
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.
- Institute of Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
ORCID-Profile: Thomas Stamminger
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Forschungsgemeinschaft in the framework of Research Unit FOR5200 DEEP-DV
- International Graduate School in Molecular Medicine Ulm
Zitieren
APA
Kuderna, A. K., Reichel, A., Tillmanns, J., Class, M., Scherer, M., & Stamminger, T. (2024). Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus. Viruses. https://doi.org/10.3390/v16030363
Vancouver
Kuderna AK, Reichel A, Tillmanns J, Class M, Scherer M, Stamminger T. Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus. Viruses. 2024. doi:10.3390/v16030363
BibTeX
@article{Kuderna2024,
author = {Kuderna, Anna K and Reichel, Anna and Tillmanns, Julia and Class, Maja and Scherer, Myriam and Stamminger, Thomas},
title = {Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16030363}
}
EUVIMED